Patents Assigned to Brightseed, Inc.
  • Publication number: 20260256733
    Abstract: Disclosed herein are compositions and methods for treating, preventing, reducing, modulating, or ameliorating stress, symptoms of stress, or deleterious effects of chronic stress, by providing the composition and a carrier. The methods may include, for example, administering a therapeutically effective compound of a plant extract. The compositions and methods may be capable of modulating mGlu2 and/or mGlu3 receptors.
    Type: Application
    Filed: March 8, 2024
    Publication date: September 3, 2026
    Applicant: BRIGHTSEED, INC.
    Inventors: Nicholas WOODWARD, Chuan WANG, Ilan Edmond CHEMMAMA, Pranatchareeya CHANKHAMJON, Meng XU, Lee Heil CHAE
  • Patent number: 12285392
    Abstract: A method for modulating metabolism is provided which includes the step of providing a consumable composition including an extract containing a compound of Formula I to a subject in need thereof thereby modulating the subject's metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.
    Type: Grant
    Filed: May 8, 2023
    Date of Patent: April 29, 2025
    Assignees: Brightseed, Inc., Sanford Burnham Prebys Medical Discovery Institute
    Inventors: Lee Heil Chae, Fred Levine
  • Patent number: 11647776
    Abstract: This disclosure relates to methods and compositions with enhanced levels of one or more tyramine containing hydroxycinnamic acid amides. Also disclosed herein are methods for producing a consumable product with enhanced levels of a tyramine containing hydroxycinnamic acid amide. Some embodiments relate to a composition enriched with a tyramine containing hydroxycinnamic acid.
    Type: Grant
    Filed: November 12, 2021
    Date of Patent: May 16, 2023
    Assignee: Brightseed, Inc.
    Inventors: Lee Heil Chae, James Flatt, Alexandra Marcela Herrmann, Gabriel Navarro, Jessica Leigh Ochoa
  • Patent number: 11642323
    Abstract: A method for modulating metabolism is provided which includes the step of providing a consumable composition including an extract containing a compound of Formula I to a subject in need thereof thereby modulating the subject's metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.
    Type: Grant
    Filed: July 20, 2022
    Date of Patent: May 9, 2023
    Assignee: Brightseed, Inc.
    Inventor: Lee Heil Chae
  • Patent number: 11382880
    Abstract: Disclosed herein are methods for improving digestive health by providing a consumable composition. Some embodiments provided include, for example, administering a compound of Formula (I) or compound of Formula (II). Some embodiments provide the composition is formulated as a dietary supplement, food ingredient or additive, a medical food, nutraceutical or pharmaceutical composition.
    Type: Grant
    Filed: January 4, 2021
    Date of Patent: July 12, 2022
    Assignees: Brightseed, Inc., Sanford-Burnham Medical Research Institute
    Inventors: Lee Heil Chae, Fred Levine
  • Patent number: 11173136
    Abstract: A method for modulating metabolism is provided which includes the step of providing a consumable composition including an extract containing a compound of Formula I to a subject in need thereof thereby modulating the subject's metabolism and addressing the underlying pathogenesis of metabolic disorders, such as nonalcoholic fatty liver disease, nonalcoholic steatohepatitis and type II diabetes mellitus.
    Type: Grant
    Filed: January 10, 2019
    Date of Patent: November 16, 2021
    Assignee: Brightseed, Inc.
    Inventor: Lee Heil Chae